The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
2688 results found
‘In Australia, 15 per cent of the population are aged 65+, estimated to grow to 21 per cent (8.4 million) by 20501.’
Dietary change is a significant lifestyle factor in managing the epidemics of obesity and diabetes. Uncovering the details of effective dietary change requires accurate user friendly dietary assessment and advice tools.
One in eight Australian women will be diagnosed with breast cancer in their lifetime and seven women die from the disease each day in Australia1
Dr Craig Smith and a team of scientists at the Florey Institute of Neuroscience and Mental Health’s Addiction Neuroscience Laboratory are investigating one of the receptors in the brain they think are responsible for those seriously rewarding feelings. Not only does this have the potential to help with obesity but it is closely linked with addictions to opioids such as heroin and could lead to a new group of targeted drugs.
Associate Professor Leah Cosgrove and her team have developed a simple blood test to diagnose colorectal cancer. A reliable, non-invasive blood test could augment the National Bowel Cancer Screening Program, either as an adjunct primary screen for those unable to do the stool test, or in triaging positive subjects to colonoscopy. This could help drive a significant reduction in colorectal cancer deaths in Australia.
‘There has been a 73 per cent reduction in children hospitalised from severe chicken pox infection since the introduction of the (varicella) vaccine to the National Immunisation Program in Australia in 2005.'1
Professor Greg Fox is a respiratory doctor and clinical trialist at the University of Sydney and Director of the Sydney Vietnam Institute who is contributing to the momentum towards tuberculosis (TB) elimination. Professor Fox received the 2021 NHMRC David Cooper Clinical Trials and Cohort Studies Award, recognising the highest ranked recipient in the Clinical Trials and Cohort Studies scheme.
As an infectious disease physician and researcher in HIV, vaccine development and the impact of the microbiome on human health, Professor Wesselingh brings a wealth of medical experience, clinical leadership as well as national and international success to this role.
Associate Professor James St John from Griffith University received the Marshall and Warren Innovation Award at the 2020 NHMRC Research Excellence Awards. His research involves the development of cell transplantation therapies to repair the nervous system, particularly peripheral nerve and spinal cord injuries.
Breastfeeding infants exclusively to around six months, and continuing up to 12 months and beyond as solids foods are introduced, provides clear benefits for both the infant and the mother. Supporting women to continue to breastfeed is key to improving rates of breastfeeding.
Professor Anne Tiedemann’s research aims to develop and evaluate exercise-based programs for preventing falls to promote healthy ageing in older people. Her research aims to determine the barriers, enablers and preferences of older people, so that exercise programs can be implemented more effectively.
‘Melanoma is the most common cancer for 15-39 year old Australians—with the highest ‘years of life lost’ of any cancer’1
Associate Professor Jaqui Hughes from the Menzies School of Health Research received the 2019 NHMRC Clinical Trials and Cohort Studies Award at NHMRC’s Research Excellence Awards ceremony in March 2020. Kidney disease is a significant health priority among Aboriginal and Torres Strait Islander communities. The cohort study being led by A/Professor Hughes will describe the long-term changes in kidney function over 10 years. This will provide critical data to inform regional and national policy on identification and care of people with kidney disease.
‘18 per cent of all Indigenous Australian adults have chronic kidney disease—two times as likely as non-Indigenous Australians.’
Coeliac disease is a common autoimmune-like illness caused by gluten. The condition affects over 350,000 Australians, causing substantial morbidity, impaired quality of life and increased health care costs.
In Australia, there is an excess burden of stroke in regional and rural areas and patients do not have the same access to specialised care as in metropolitan areas.
Drugs already approved and available could be the answer to boost the production of killer T cells and improve the success rate of immunotherapies for cancer.
Professor Sarah Robertson from The University of Adelaide is recipient of an NHMRC Investigator Award and was awarded the Elizabeth Blackburn Investigator Grant Award (Leadership in Basic Science) at the 2020 NHMRC Research Excellence Awards.
‘I have just felt really privileged for most of my life, I love my work, I love what I do, and I really enjoy the people I work with, and it comes from spending part of my career in medical research. It just gives you a lot of flexibility and opportunities that you don’t get with standard clinical hospital jobs or general practice.’
The Healthy Environments and Lives National Research Network (HEAL) was announced at the end of 2021 with a grant of $10 million over five years, as an NHMRC Special Initiative to provide national and international leadership in environmental change and health research. HEAL formally starts in May 2022; a lot of groundwork has been done to create the foundations for a large and diverse collaboration to deliver its ambitious work plan over the next five years and beyond.